AGNG

Aging Population ETF

Invest in AGNG
Overview Prices & Performance Holdings & Characteristics Research Documents

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2021

Key Information As of 05/26/22

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $50.97 million
NAV $25.87
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 05/26/22

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 1,970,000
Number of Holdings 99
30-Day Median Bid-Ask Spread 0.27%

Distributions As of 05/26/22

30-Day SEC Yield 0.84%
Distribution Frequency Semi-Annually
 Distribution History

ETF Prices As of 05/26/22

NAV $25.87 Daily Change $0.06 0.24%
Market Price $25.96 Daily Change $0.10 0.40%

Performance History

Premium Discount Chart
As of recent
(03/31/22)
As of recent
(03/31/22)
Fund NAV Market Price Index
1 Year 4.32% 4.02% 4.46%
3 Years 10.88% 10.69% 11.09%
5 Years 12.10% 11.95% 12.34%
Since Inception 12.17% 12.57% 12.45%
1 Year -7.39% -7.35% -7.30%
3 Years 9.54% 9.42% 9.75%
5 Years 9.66% 9.53% 9.90%
Since Inception 10.63% 11.03% 10.91%
Year-to-Date -0.59% -0.52% -0.57%
1 Month 5.83% 5.91% 5.82%
3 Months -0.59% -0.52% -0.57%
Since Inception 96.77% 100.92% 99.78%
Year-to-Date -7.60% -7.46% -7.57%
1 Month -7.05% -6.98% -7.04%
3 Months 0.08% -0.04% 0.08%
Since Inception 82.90% 86.90% 85.72%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 05/26/22

Full Holdings (.csv)
Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.49 BMY BRISTOL-MYERS SQUIBB CO 2126335 77.59 22,926 1,778,828.34
3.47 LLY ELI LILLY & CO 2516152 313.46 5,648 1,770,422.08
3.43 AMGN AMGEN INC 2023607 253.05 6,911 1,748,828.55
3.34 JNJ JOHNSON & JOHNSON 2475833 179.46 9,479 1,701,101.34
3.27 AZN ASTRAZENECA PLC-SPONS ADR 2989044 66.70 25,010 1,668,167.00
3.27 REGN REGENERON PHARMACEUTICALS 2730190 683.44 2,439 1,666,910.16
3.12 NOVOB DC NOVO NORDISK A/S-B BHC8X90 106.39 14,929 1,588,292.15
3.12 ALC SW ALCON INC BJT1GR5 72.66 21,856 1,588,038.10
3.09 WELL WELLTOWER INC BYVYHH4 88.58 17,799 1,576,635.42
3.05 BSX BOSTON SCIENTIFIC CORP 2113434 40.14 38,752 1,555,505.28
3.02 ABBV ABBVIE INC B92SR70 150.57 10,228 1,540,029.96
3.02 MDT MEDTRONIC PLC BTN1Y11 99.44 15,463 1,537,640.72
2.97 SYK STRYKER CORP 2853688 234.94 6,442 1,513,483.48
2.88 RO SW ROCHE HOLDING AG-BR 7108918 393.28 3,738 1,470,063.39
2.78 4519 JP CHUGAI PHARMA CO 6196408 27.06 52,336 1,416,041.78
2.77 EW EDWARDS LIFESCIENCES CORP 2567116 98.57 14,305 1,410,043.85
2.17 BIIB BIOGEN INC 2455965 204.22 5,410 1,104,830.20
2.12 4503 JP ASTELLAS PHARMA INC 6985383 15.99 67,578 1,080,611.10
1.86 DXCM DEXCOM INC B0796X4 280.63 3,379 948,248.77
1.83 SGEN SEAGEN INC BLPK4D2 138.46 6,730 931,835.80
1.82 ZBH ZIMMER BIOMET HO 2783815 120.65 7,704 929,487.60
1.77 4543 JP TERUMO CORP 6885074 32.21 27,952 900,303.57
1.63 VTR VENTAS INC 2927925 56.38 14,705 829,067.90
1.53 SOON SW SONOVA HOLDING AG-REG 7156036 335.61 2,325 780,284.18
1.44 GMAB DC GENMAB A/S 4595739 304.07 2,419 735,553.84
1.33 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 115.86 5,860 678,934.06
1.29 FME GR FRESENIUS MEDICA 5129074 60.75 10,782 654,974.29
1.24 UCB BB UCB SA 5596991 88.59 7,158 634,135.66
1.22 INCY INCYTE CORP 2471950 76.02 8,143 619,030.86
1.21 068270 KS CELLTRION INC B0C5YV1 121.55 5,076 616,972.38
1.15 PODD INSULET CORP B1XGNW4 229.06 2,547 583,415.82
1.04 SN/ LN SMITH & NEPHEW PLC 0922320 16.40 32,148 527,317.91
0.97 BGNE BEIGENE LTD-ADR BYYWPW6 131.26 3,775 495,506.50
0.97 TFX TELEFLEX INC 2881407 285.47 1,725 492,435.75
0.86 ABMD ABIOMED INC 2003698 260.97 1,674 436,863.78
0.73 COH AU COCHLEAR LTD 6211798 154.55 2,418 373,701.64
0.73 UTHR UNITED THERAPEUTICS CORP 2430412 224.78 1,658 372,685.24
0.71 3692 HK HANSOH PHARMACEU BJYKB72 1.66 217,643 362,107.56
0.70 DEMANT DC DEMANT A/S BZ01RF1 40.62 8,826 358,511.75
0.68 DVA DAVITA INC 2898087 97.44 3,540 344,937.60
0.63 EXAS EXACT SCIENCES CORP 2719951 49.86 6,402 319,203.72
0.62 NBIX NEUROCRINE BIOSC 2623911 89.84 3,500 314,440.00
0.60 NVCR NOVOCURE LTD BYSS4X4 80.19 3,837 307,689.03
0.56 AMP IM AMPLIFON SPA B14NJ71 34.57 8,321 287,696.76
0.56 AGL AGILON HEALTH INC BLR4TK4 19.22 14,742 283,341.24
0.51 OHI OMEGA HEALTHCARE 2043274 29.52 8,777 259,097.04
0.46 HALO HALOZYME THERAPEUTICS INC 2975098 46.60 5,055 235,563.00
0.42 EXEL EXELIXIS INC 2576941 18.19 11,731 213,386.89
0.39 MNKD MANNKIND CORP BF081J4 4.57 43,718 199,791.26
0.38 GN DC GN STORE NORD A/S 4501093 36.89 5,254 193,816.17
0.38 LHCG LHC GROUP INC B06DT50 166.22 1,162 193,147.64
0.36 RYM NZ RYMAN HEALTHCARE LTD 6161525 6.69 27,301 182,579.40
0.35 NHI NATL HEALTH INVESTORS INC 2626125 58.40 3,042 177,652.80
0.35 NUVA NUVASIVE INC B00GJC2 55.76 3,184 177,539.84
0.35 LTC LTC PROPERTIES INC 2498788 38.48 4,605 177,200.40
0.34 ITGR INTEGER HOLDINGS CORP BD06LM7 78.89 2,212 174,504.68
0.34 4547 JP KISSEI PHARM CO 6494061 19.60 8,753 171,588.36
0.34 SBRA SABRA HEALTH CAR B5NLBP6 13.88 12,317 170,959.96
0.33 CANO CANO HEALTH INC BN0WWW2 5.52 30,650 169,188.00
0.33 KORI FP KORIAN B1HKRM0 21.24 7,948 168,832.71
0.33 PNTG PENNANT GROUP INC/THE BKTC976 17.95 9,392 168,586.40
0.33 NHC NATIONAL HEALTHCARE CORP 2139731 68.15 2,435 165,945.25
0.32 8086 JP NIPRO CORP 6641599 8.00 20,508 164,128.43
0.32 ENSG ENSIGN GROUP INC/THE B1YWPP8 80.60 2,019 162,731.40
0.31 MMSI MERIT MEDICAL SYSTEMS INC 2580555 60.79 2,622 159,391.38
0.31 CSH-U CN CHARTWELL RETIRE B8S8C94 9.70 16,418 159,221.18
0.31 PHM SM PHARMA MAR SA BMW2GT8 75.71 2,082 157,625.51
0.31 AED BB AEDIFICA B1G5XP1 116.50 1,352 157,507.53
0.31 TBPH THERAVANCE BIOPHARMA INC BMNDK09 8.91 17,636 157,136.76
0.31 EKTAB SS ELEKTA AB-B SHS B0M42T2 7.07 22,023 155,595.59
0.30 1858 HK BEIJING CHUNLI-H BVVPXP6 1.10 140,916 154,386.20
0.30 ANGO ANGIODYNAMICS INC B00CR04 19.10 7,960 152,036.00
0.29 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 10.60 13,788 146,214.32
0.28 AMED AMEDISYS INC 2024332 117.39 1,220 143,215.80
0.28 BKD BROOKDALE SR B0PZN33 5.63 25,366 142,810.58
0.28 LIVN LIVANOVA PLC BYMT0J1 66.02 2,150 141,943.00
0.28 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.30 469,424 141,132.49
0.28 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.53 265,789 140,180.32
0.27 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.28 497,192 138,713.25
0.27 BPMC BLUEPRINT MEDICINES CORP BWY52P3 55.36 2,453 135,798.08
0.27 DHC DIVERSIFIED HEAL BKRN595 2.28 59,304 135,213.12
0.26 INGN INOGEN INC BJSVLL5 25.86 5,209 134,704.74
0.25 853 HK MICROPORT SCIENTIFIC CORP B676TW7 1.72 73,902 127,098.28
0.25 2500 HK VENUS MEDTECH -H BL6V047 1.44 87,040 125,077.07
0.24 FGEN FIBROGEN INC BSDRYR8 9.22 13,463 124,128.86
0.24 DNLI DENALI THERAPEUTICS INC BD2B4V0 24.16 5,127 123,868.32
0.24 ORP FP ORPEA 7339451 28.05 4,403 123,494.46
0.24 SILK SILK ROAD MEDICAL INC BGHVXJ7 30.50 3,989 121,664.50
0.23 SGHT SIGHT SCIENCES INC BN2T5Q6 8.13 14,399 117,063.87
0.23 RDUS RADIUS HEALTH INC BM68KK1 6.10 19,104 116,534.40
0.23 GKOS GLAUKOS CORP BYMWL19 40.65 2,835 115,242.75
0.22 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 19.39 5,718 110,872.02
0.21 CMAX CAREMAX INC BMD9BG0 4.81 22,518 108,311.58
0.21 ALEC ALECTOR INC BJ4LDC4 8.89 12,173 108,217.97
0.21 AERI AERIE PHARMACEUTICALS INC BFRTDG1 5.43 19,885 107,975.55
0.21 ATEC ALPHATEC HOLDINGS INC BD60BG7 7.86 13,335 104,813.10
0.20 ACAD ACADIA PHARMACEU 2713317 16.23 6,293 102,135.39
0.17 HRTX HERON THERAPEUTICS INC BJ0XLZ3 3.18 27,244 86,635.92
0.13 CASH 1.00 66,831 66,742.44
0.13 AMRN AMARIN CORP PLC -ADR 2301938 1.43 46,424 66,386.32
Holdings are subject to change.

Sector Breakdown As of 04/30/22

Sector Weight (%)
Health Care 93.5
Real Estate 6.5

Source: AltaVista Research, LLC

Country Breakdown As of 04/30/22

Country Weight (%)
United States 57.6
Switzerland 8.9
Japan 7.2
Denmark 6.1
Britain 5.0
China 3.6
Ireland 3.3
Belgium 1.9
South Korea 1.4
Germany 1.3
Australia 0.8
Other/Cash 2.9

Source: AltaVista Research, LLC

ETF Characteristics As of 05/26/22

Return on Equity 12.50%
Weighted Avg. Market Cap 87,793 M
2021 2022
Price-to-earnings 25.07 25.62
Price-to-book value 3.33 3.09

Source: AltaVista Research, LLC

ETF Risk Stats As of 05/26/22

Versus Beta
S&P 500 0.78
MSCI EAFE 0.78
MSCI Emg. Mkts 0.61
Standard Deviation 17.60%

Source: AltaVista Research, LLC

ETF Documents

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

Back to Top